Organization: Health Canada
Year: 2022
Month: August
Request Number: A-2021-002083
Request Summary: Adverse Drug Reactions (ADRs) for ANTI-THYMOCYTE GLOBULIN (RABBIT), DUPILUMAB, ALEMTUZUMAB. Report numbers: E2B_04926642, E2B_04731617, E2B_04876141, E2B_04937460, E2B_04703758, E2B_04713387, E2B_02395265, E2B_04702989, E2B_04685799, 973025.
Disposition: Disclosed in part
Number of pages: 155